Advanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications

ACS Nano. 2023 May 23;17(10):8935-8965. doi: 10.1021/acsnano.3c02303. Epub 2023 May 1.

Abstract

Nitric oxide (NO), a gaseous transmitter extensively present in the human body, regulates vascular relaxation, immune response, inflammation, neurotransmission, and other crucial functions. Nitrite donors have been used clinically to treat angina, heart failure, pulmonary hypertension, and erectile dysfunction. Based on NO's vast biological functions, it further can treat tumors, bacteria/biofilms and other infections, wound healing, eye diseases, and osteoporosis. However, delivering NO is challenging due to uncontrolled blood circulation release and a half-life of under five seconds. With advanced biotechnology and the development of nanomedicine, NO donors packaged with multifunctional nanocarriers by physically embedding or chemically conjugating have been reported to show improved therapeutic efficacy and reduced side effects. Herein, we review and discuss recent applications of NO nanomedicines, their therapeutic mechanisms, and the challenges of NO nanomedicines for future scientific studies and clinical applications. As NO enables the inhibition of the replication of DNA and RNA in infectious microbes, including COVID-19 coronaviruses and malaria parasites, we highlight the potential of NO nanomedicines for antipandemic efforts. This review aims to provide deep insights and practical hints into design strategies and applications of NO nanomedicines.

Keywords: Bacterial; Biofilm; Biotechnology; Cancer; Coronavirus; Glaucoma; Nitric oxide nanomedicine; Osteoporosis; Wound healing.

Publication types

  • Review
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Drug Carriers / therapeutic use
  • Humans
  • Male
  • Neoplasms* / therapy
  • Nitric Oxide / therapeutic use
  • Nitric Oxide Donors

Substances

  • Nitric Oxide
  • Drug Carriers
  • Nitric Oxide Donors